Cost-effectiveness of dexamphetamine and methylphenidate for the treatment of childhood attention deficit hyperactivity disorder

References

• Mathers C D, Vos T, Stevenson C. The burden of disease and injury in Australia. Australian Institute of Health and Welfare, Canberra 1999
   Google Scholar
• Elia J, Abrosini P J, Rappaport J L. Treatment of attention-deficit hyperactivity disorder. New England Journal of Medicine 1999; 340: 780–788
   PubMed Web of Science ®Google Scholar
• Miller A, Lee S, Raina P, Klassen A, Zupancic J, Olsen L. A review of therapies for attention-deficit/hyperactivity disorder. Canadian Coordinating Office for Health Technology Assessment, Ottawa 1999
   Google Scholar
• Sawyer M M, Arney F M, Baghurst P A, et al. The mental health of young people in Australia. Mental Health and Special Programs Branch Commonwealth Department of Health and Aged Care, Canberra 2000
   Google Scholar
• Landgraf J M, Abetz L, Ware J E. Child Health Questionnaire (CHQ): a user's manual. The Health Institute, New England Medical Centre, Boston 1996
   Google Scholar
• Pliszka S R, Greenhill L L, Crimson M L, et al. The Texas children's medication algorithm project: report of the Texas consensus conference panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part II: tactics. Journal of the American Academy of Child and Adolescent Psychiatry 2000; 39: 920–927
   PubMed Web of Science ®Google Scholar
• The MTA Co-operative Group. A 14-month randomised clinical control trial of treatment strategies for ADHD. Archives of General Psychiatry 1999; 56: 1073–1086
   PubMedGoogle Scholar
• Jadad A R, Boyle M, Cunningham C, Kim M, Schachar R. Treatment of attention-deficit/hyperactivity disorder: evidence report/technology assessment no. 11. Agency for Health Care Policy and Research, Rockville, MD 1999
   Google Scholar
• Schachter H, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal 2001; 165: 1475–1488
   PubMed Web of Science ®Google Scholar
• DuPaul G, Eckert T L. The effects of school-based interventions for attention deficit hyperactivity disorder: a meta-analysis. School Psychology Review 1997; 26: 5–27
   Web of Science ®Google Scholar
• Gaub M, Carlson C. Gender differences in ADHD: a meta-analysis and critical review. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36: 1036–1045
   PubMed Web of Science ®Google Scholar
• Klassen A, Miller A, Raina P, Lee S K, Olsen L. Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies. Canadian Journal of Psychiatry 1999; 44: 1007–1016
   PubMed Web of Science ®Google Scholar
• Jadad A R, Booker L, Gauld M, et al. The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and meta-analyses. Canadian Journal of Psychiatry 1999; 44: 1025–1035
   PubMed Web of Science ®Google Scholar
• Egger M, Smith G, Altman D. Systematic reviews in health care: meta-analysis in context 2nd edn. BMJ Books, London 2001
   Google Scholar
• Elbourne D, Altman D, Higgins JPT, Curtin F, Worthington H V, Vail A. Meta-analysis involving cross-over trials: methodological issues. International Journal of Epidemiology 2002; 31: 140–149
   PubMed Web of Science ®Google Scholar
• Dunlap W P, Cortina J M, Vaslow J B, Burke M J. Meta-analysis of experiments with matched groups or repeated measures designs. Psychological Methods 1996; 1: 170–177
   Web of Science ®Google Scholar
• Deeks J, Altman D, Bradburn M. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. Systematic reviews in health care: meta-analysis in context 2nd edn., M Egger, G Smith, D Altman. BMJ Publishing Group, London 2001; 285–312
   Google Scholar
• Elia J, Welsh P A, Gullotta C S, Rapoport J L. Classroom academic performance: improvement with both methylphenidate and dextroamphetamine in ADHD boys. Journal of Child Psychology and Psychiatry 1993; 34: 785–804
   PubMedGoogle Scholar
• James R S, Sharp W S, Bastain T M, et al. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 2001; 40: 1268–1276
   PubMed Web of Science ®Google Scholar
• Amery B, Minichiello M D, Brown G L. Aggression in hyperactive boys: response to d-amphetamine. Journal of the American Academy of Child and Adolescent Psychiatry 1984; 23: 291–294
   Google Scholar
• Zametkin A, Rapoport J, Murphy D L, Linnoila M, Ismond D. Treatment of hyperactive children with monoamine oxidase inhibitors. Archives of General Psychiatry 1985; 42: 962–966
   PubMed Web of Science ®Google Scholar
• Brown R T, Borden K A, Wynne M E, Spunt A L, Clingerman S R. Compliance with pharmacological and cognitive treatments for attention deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1987; 26: 521–526
   PubMedGoogle Scholar
• DuPaul G J, Rapport M D. Does methylphenidate normalise the classroom performance of children with attention deficit disorder?. Journal of the American Academy of Child and Adolescent Psychiatry 1993; 32: 190–198
   PubMed Web of Science ®Google Scholar
• Fitzpatrick P A, Klorman R, Brumaghim J T, Borgstedt A D. Effects of sustained-release and standard preparations of methylphenidate on attention-deficit disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1992; 31: 226–243
   PubMed Web of Science ®Google Scholar
• McBride M C. An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder. Pediatric Pharmacology and Therapeutics 1988; 113: 137–145
   Google Scholar
• Rapport M D, DuPaul G J, Kelly K L. Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children. Psychopharmacology Bulletin 1989; 25: 285–290
   PubMed Web of Science ®Google Scholar
• Schachar R, Tannock R, Cunningham C, Corkum P V. Behavioural, situational, and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36: 754–763
   PubMed Web of Science ®Google Scholar
• Stein M T, Blondis T A, Schnitzler E, et al. Methylphenidate dosing: twice daily versus three times daily. Pediatrics 1996; 98: 748–756
   PubMed Web of Science ®Google Scholar
• Rapport M D, Jones J T, DuPaul G J, et al. Attention deficit disorder and methylphenidate: group and single-subject analysis of dose effects on attention in clinic and classroom settings. Journal of Clinical Child Psychology 1987; 16: 329–338
   Web of Science ®Google Scholar
• Wolraich M L, Greenhill L L, Pelham W E, et al. Randomised, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics 2001; 108: 883–892
   PubMed Web of Science ®Google Scholar
• Zeiner P, Bryhn G, Bjercke C, Truyen K, Strand G. Response to methylphenidate in boys with attention-deficit hyperactivity disorder. Acta Paediatrica 1999; 88: 298–303
   PubMed Web of Science ®Google Scholar
• Firestone P, Crowe D, Goodman J T, McGrath P. Vicissitudes of follow-up studies: differential effects of parent training and stimulant medication with hyperactives. American Journal of Orthopsychiatry 1986; 56: 184–194
   PubMedGoogle Scholar
• Brown R T, Wynne M E, Borden K A, Clingerman SRRG, Spunt A L. Methylphenidate and cognitive therapy in children with attention deficit disorder: a double-blind trial. Developmental and Behavioural Pediatrics 1986; 7: 163–170
   PubMed Web of Science ®Google Scholar
• Smith B H, Pelham W E, Evans S W, et al. Dosage effects of methylphenidate on the social behaviour of adolescents diagnosed with attention-deficit hyperactivity disorder. Experimental and Clinical Psychopharmacology 1998; 6: 187–204
   PubMed Web of Science ®Google Scholar
• Carlson C, Pelham W E, Milich R, Dixon J. Single and combined effects of methylphenidate and behaviour therapy on the classroom performance of children with attention-deficit hyperactivity disorder. Journal of Abnormal Child Psychology 1992; 20: 213–232
   PubMed Web of Science ®Google Scholar
• Stouthard M, Essink-Bot M, Bonsel G, et al. Disability weights for diseases in the Netherlands. Department of Public Health. Erasmus University, Rotterdam 1997
   Google Scholar
• Haby M, Carter R, Mihalopoulos C, Magnus A, Andrews G, Vos T. Assessing Cost-Effectiveness (ACE) –Mental Health: introduction to the study and methods. Australian and New Zealand Journal of Psychiatry 2004; 38: 569–578
   PubMed Web of Science ®Google Scholar
• Thiruchelvam D, Charach A, Schachar R J. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 2001; 40: 922–928
   PubMed Web of Science ®Google Scholar
• Pharmacy Direct. Pharmacy direct: medicine by mail. 2002, (Available at: http://www.pharmacydirect.com.au Accessed 11 September 2002.)
   Google Scholar
• Arrow Pharmaceuticals. Private prescription product range. 2002, (Available at: http://www.arrowpharma.com/about.cfm Accessed 10 September 2002)
   Google Scholar
• Caswell A. MIMS, A Caswell. MediMedia Australia, Sydney, NSW 2001
   Google Scholar
• Kauffman R E, Smith-Wright D, Reese C A, Simpson R, Jones F. Medication compliance in hyperactive children. Pediatric Pharmacology 1981; 1: 123–237
   Google Scholar
• Gillberg C, Melander H, von Knorring A, et al. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms: a randomised, double-blind, placebo-controlled trial. Archives of General Psychiatry 1997; 54: 857–864
   PubMed Web of Science ®Google Scholar
• Fine S, Worling D. Issues in medication adherence for children and adolescents with attention-deficit hyperactivity disorder. British Columbia Medical Journal 2001; 43: 277–281
   Google Scholar
• American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics 2001; 108: 1033–1044
   PubMed Web of Science ®Google Scholar
• Harris A. Economic evaluation and the reimbursement of pharmaceuticals in Australia. Centre for Health Program Evaluation, Melbourne 1994
   Google Scholar
• Zupancic J, Miller A, Raina P, Lee P P, Klassen A, Olsen L. Economic evaluation of pharmaceutical and psychological/ behavioural therapies for attention-deficit/hyperactivity disorder. Canadian Coordinating Office for Health Technology Assessment (CCOHTA), Ottowa 1999
   Google Scholar
• Jensen P S, Martin D, Cantwell D P. Comorbidity in ADHD. implications for research, practice, and DSM-V. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36: 1065–1079
   PubMed Web of Science ®Google Scholar
• National Institute of Health. Diagnosis and treatment of attention deficit hyperactivity disorder. NIH Consensus Statement online. National Institute of Health, Bethesda, ML 1998, (Available at: http://Odp Od Nih Gov/Consensus/Cons/110/110_Statement Htm Accessed 27 February 2002.)
   Google Scholar
• Klein R G, Abikoff H B. Behaviour therapy and methylphenidate in the treatment of children with ADHD. Journal of Attention Disorders 1997; 2: 89–114
   Google Scholar
• Pelham W E, Fabiano G A. Behaviour modification. Child and Adolescent Psychiatric Clinics of North America 2001; 9: 671–688
   Google Scholar